Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,867 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Risk analysis for hepatocellular carcinoma in patients with chronic hepatitis B-associated cirrhosis complicated by type 2 diabetes mellitus: a 5-year prospective cohort study].
Tang C, Hu C, Zhou Y, Song Y, Li M, Liao M, Sun J, Zhong C, Zhou L, Lin Z, Zhou Y. Tang C, et al. Among authors: liao m. Nan Fang Yi Ke Da Xue Xue Bao. 2021 Mar 25;41(3):313-318. doi: 10.12122/j.issn.1673-4254.2021.03.01. Nan Fang Yi Ke Da Xue Xue Bao. 2021. PMID: 33849820 Free PMC article. Chinese.
A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer.
Lu S, Li L, Luo Y, Zhang L, Wu G, Chen Z, Huang C, Guo S, Zhang Y, Song X, Yu Y, Zhou C, Li W, Liao M, Li B, Xu L, Chen P, Hu C, Hu C. Lu S, et al. Among authors: liao m. J Thorac Oncol. 2015 Jan;10(1):206-11. doi: 10.1097/JTO.0000000000000343. J Thorac Oncol. 2015. PMID: 25654728 Free article. Clinical Trial.
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel.
Wu YL, Wang CL, Liao ML, Guan ZZ, Gao CY, Lu S, Zhao MF, Wang J, Liu XQ, Yang JJ, Liang J, Mao WM, Han BH, Zhang XC, Song Y, Feng JF, Ma SL, Wu G, Zhou CC, Chen KN, Cheng Y, He Y, Chen C, Wang Q, Lin JZ, Zhu B, Liu YP, Hu Y, Qiao GB, Zhou Q, Song QB, Wu N, Wu L, Huang C, Fu XL, Xiong JP, Hu J, Hu CP, Chang JH, Zhao Q, Zhao J, Zhou PH, Ma ZY, Chen Y, Zhang HL, Yang F, Wang JJ, Pan YY, Yang XN, Fan Y, Liu Z, Fan W, Yang N, Guan YF, Sun H, Zhong WZ. Wu YL, et al. Transl Lung Cancer Res. 2018 Jun;7(3):428-436. doi: 10.21037/tlcr.2018.04.15. Transl Lung Cancer Res. 2018. PMID: 30050780 Free PMC article. Review.
[The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
Liao ML, Zhou YZ, Ding JA, Ni GX, Zhao JM, Chen WH, Han BH, Shen J, Bai H, Chen ZW, Ji H, Wang HM, Zhou Z. Liao ML, et al. Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):962-6. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12899797 Clinical Trial. Chinese.
[Guidenline for diagnosis and treatment of Alk and Ros1 positive non-small cell lung cancer in China].
Zhang XC, Lu S, Zhang L, Liao ML, Wang CL, Cheng Y, Li GD, Mok SJ, Huang C, Liu XQ, Wang J, Wang MZ, Zhang YP, Zhou JY, Zhou XJ, Zhou XY, Lin DM, Yang JJ, Song Y, Hu CP, Wang K, He Y, Li H, Zhong WZ, Wu YL; Tumor Marker Committee of Chinese Society of Clinical Oncology. Zhang XC, et al. Among authors: liao ml. Zhonghua Bing Li Xue Za Zhi. 2018 Apr 8;47(4):241-247. doi: 10.3760/cma.j.issn.0529-5807.2018.04.003. Zhonghua Bing Li Xue Za Zhi. 2018. PMID: 29690661 Chinese. No abstract available.
3,867 results